SG Americas Securities
NYMX

SG Americas Securities’s Nymox Pharmaceutical Corp NYMX Stock Holding History

SG Americas Securities’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-21,288
Closed -$76K – 3659
2020
Q2 		$76K Buy
+21,288
New +$67.3K ﹤0.01% 3454
2019
Q1 		– Sell
-13,333
Closed -$17K – 3702
2018
Q4 		$17K Buy
+13,333
New +$24.4K ﹤0.01% 2925

Other funds holding NYMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SG Americas Securities's NYMX Position: Q3 2020 in Review

SG Americas Securities sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2020, closing a stake of 21,288 shares — an estimated $76K sold.

SG Americas Securities first reported a position in NYMX in Q4 2018 and held it in 2 quarters. The position peaked at $76K in Q2 2020. 64 funds tracked by Wall St. Rank hold NYMX as of Q3 2020.

  • SG Americas Securities reported no remaining Nymox Pharmaceutical Corp position as of Q3 2020 after selling out during the quarter.
  • SG Americas Securities sold 21,288 Nymox Pharmaceutical Corp shares in Q3 2020, an estimated $76K.
  • SG Americas Securities first reported a position in Nymox Pharmaceutical Corp in Q4 2018 and held it in 2 quarters.
  • SG Americas Securities's Nymox Pharmaceutical Corp position peaked at $76K in Q2 2020.
  • 64 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.